Compugen CGEN
NASDAQ CGEN
$2.09 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Compugen (CGEN) Current Deferred Tax Liability (2013 - 2026)

Updated

Analysis

Compugen (CGEN) Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Compugen 197.62 Mn -218.36 Mn 1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.36 Mn
Dec 31, 2025 24.94 Mn
Jun 30, 2025 29.59 Mn
Dec 31, 2024 34.05 Mn
Dec 31, 2023 25.39 Mn
Sep 30, 2014 326,000.00
Jun 30, 2014 948,000.00
Dec 31, 2013 1.45 Mn
API Access

Compugen Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=CGEN&period=max&api_key=YOUR_API_KEY